{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:26:12Z","timestamp":1790083572554,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T00:00:00Z","timestamp":1313625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00535-011-0449-z","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T15:17:57Z","timestamp":1313594277000},"page":"1316-1323","source":"Crossref","is-referenced-by-count":23,"title":["Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial"],"prefix":"10.1007","volume":"46","author":[{"given":"Hisashi","family":"Hidaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akitaka","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Minamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juichi","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Okuwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasaburo","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,18]]},"reference":[{"key":"449_CR1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/jhep.2001.28231","volume":"34","author":"H Yoshiji","year":"2001","unstructured":"Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, et al. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology. 2001;34:745\u201350.","journal-title":"Hepatology."},{"key":"449_CR2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000060162","volume":"135","author":"J Gaedeke","year":"2001","unstructured":"Gaedeke J, Peters H, Noble NA, Border WA. Angiotensin II, TGF-beta and renal fibrosis. Contrib Nephrol. 2001;135:153\u201360.","journal-title":"Contrib Nephrol"},{"key":"449_CR3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/hep.1840140211","volume":"14","author":"P Nagy","year":"1991","unstructured":"Nagy P, Scaff Z, Lapis K. Immunohistochemical detection of transforming growth factor-beta 1 in fibrotic liver diseases. Hepatology. 1991;14:269\u201373.","journal-title":"Hepatology."},{"key":"449_CR4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840110412","volume":"11","author":"M Matsuoka","year":"1990","unstructured":"Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology. 1990;11:599\u2013605.","journal-title":"Hepatology."},{"key":"449_CR5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/jhep.2002.32679","volume":"36","author":"Y Terui","year":"2002","unstructured":"Terui Y, Saito T, Watanabe H, Togashi H, Kawata S, Kamada Y, et al. Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C. Hepatology. 2002;36:1022.","journal-title":"Hepatology"},{"key":"449_CR6","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/hep.20420","volume":"40","author":"S Yokohama","year":"2004","unstructured":"Yokohama S, Yoneda M, Haneda M, Okamoto S, Okada M, Aso K, et al. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology. 2004;40:1222\u20135.","journal-title":"Hepatology."},{"key":"449_CR7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2007.01.017","volume":"46","author":"W Debernardi-Venon","year":"2007","unstructured":"Debernardi-Venon W, Martini S, Biasi F, Vizio B, Termine A, Poli G, et al. AT1 receptor antagonist candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers. J Hepatol. 2007;46:1026\u201333.","journal-title":"J Hepatol"},{"key":"449_CR8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00004872-199715010-00001","volume":"15","author":"S Kim","year":"1997","unstructured":"Kim S, Iwao H. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype. J Hypertens Suppl. 1997;15:S3\u20137.","journal-title":"J Hypertens Suppl"},{"key":"449_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/thx.2003.000893","volume":"59","author":"M Otsuka","year":"2004","unstructured":"Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Thorax. 2004;59:31\u20138.","journal-title":"Thorax."},{"key":"449_CR10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.ASN.0000060574.38107.3B","volume":"14","author":"JJ Boffa","year":"2003","unstructured":"Boffa JJ, Lu Y, Placier S, Stefanski A, Dussaule JC, Chatziantoniou C. Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol. 2003;14:1132\u201344.","journal-title":"J Am Soc Nephrol"},{"key":"449_CR11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.103.053322","volume":"307","author":"T Yamada","year":"2003","unstructured":"Yamada T, Kuno A, Masuda K, Ogawa K, Sogawa M, Nakamura S, et al. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther. 2003;307:17\u201323.","journal-title":"J Pharmacol Exp Ther"},{"key":"449_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(95)00401-6","volume":"285","author":"M Mizuno","year":"1995","unstructured":"Mizuno M, Sada T, Ikeda M, Fukuda N, Miyamoto M, Yanagisawa H, et al. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. Eur J Pharmacol. 1995;285:181\u20138.","journal-title":"Eur J Pharmacol"},{"key":"449_CR13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1524-6175.2001.01136.x","volume":"3","author":"S Oparil","year":"2001","unstructured":"Oparil S, Williams D, Chrysant SG, Marbury TC, Neutel J. Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension. J Clin Hypertens (Greenwich). 2001;3:283\u201391 (318).","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"449_CR14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1440-1746.1996.tb00289.x","volume":"11","author":"Y Murawaki","year":"1996","unstructured":"Murawaki Y, Ikuta Y, Nishimura Y, Koda M, Kawasaki H. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis. J Gastroenterol Hepatol. 1996;11:443\u201350.","journal-title":"J Gastroenterol Hepatol"},{"key":"449_CR15","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/1097-0142(19940501)73:9<2275::AID-CNCR2820730907>3.0.CO;2-T","volume":"73","author":"Y Shirai","year":"1994","unstructured":"Shirai Y, Kawata S, Tamura S, Ito N, Tsushima H, Takaishi K, et al. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer. 1994;73:2275\u20139.","journal-title":"Cancer."},{"key":"449_CR16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-2008-1040613","volume":"6","author":"J Bosch","year":"1986","unstructured":"Bosch J, Mastai R, Kravetz D, Navasa M, Rodes J. Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis. 1986;6:309\u201317.","journal-title":"Semin Liver Dis"},{"key":"449_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1443-1661.2009.00929.x","volume":"22","author":"G Tajiri","year":"2010","unstructured":"Tajiri G, Yoshida H, Obara K, Onji M, Kage M, Kitano S, et al. General rules for recording endoscopic findings of esophagogastric varices (2nd edn). Dig Endosc. 2010;22:1\u20139.","journal-title":"Dig Endosc."},{"key":"449_CR18","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1872-034X.2007.00165.x","volume":"37","author":"H Hidaka","year":"2007","unstructured":"Hidaka H, Kokubu S, Nakazawa T, Okuwaki Y, Ono K, Watanabe M, et al. New angiotensin II type 1 receptor blocker olmesartan improves portal hypertension in patients with cirrhosis. Hepatol Res. 2007;37:1011\u20137.","journal-title":"Hepatol Res."},{"key":"449_CR19","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/hep.22273","volume":"47","author":"G Garcia-Tsao","year":"2008","unstructured":"Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding\u2014unresolved issues. Summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver single-topic conference. Hepatology. 2008;47:1764\u201372.","journal-title":"Hepatology."},{"key":"449_CR20","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","volume":"353","author":"RJ Groszmann","year":"2005","unstructured":"Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254\u201361.","journal-title":"N Engl J Med"},{"key":"449_CR21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","volume":"118","author":"R Bataller","year":"2000","unstructured":"Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology. 2000;118:1149\u201356.","journal-title":"Gastroenterology"},{"key":"449_CR22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/hep.510250102","volume":"25","author":"D Rockey","year":"1997","unstructured":"Rockey D. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology. 1997;25:2\u20135.","journal-title":"Hepatology."},{"key":"449_CR23","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00004872-200106001-00005","volume":"19","author":"K Bergmann Von","year":"2001","unstructured":"Von Bergmann K, Laeis P, Puchler K, Sudhop T, Schwocho LR, Gonzalez L. Olmesartan medoxomil: influence of age, renal and hepatic function on the pharmacokinetics of olmesartan medoxomil. J Hypertens Suppl. 2001;19:S33\u201340.","journal-title":"J Hypertens Suppl"},{"key":"449_CR24","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2003.07497.x","volume":"98","author":"BK De","year":"2003","unstructured":"De BK, Bandyopadhyay K, Das TK, Das D, Biswas BK, Majumdar D, et al. Portal pressure response to losartan compared with propranolol in patients with cirrhosis. Am J Gastroenterol. 2003;98:1371\u20136.","journal-title":"Am J Gastroenterol"},{"key":"449_CR25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/gast.2001.26295","volume":"121","author":"M Schepke","year":"2001","unstructured":"Schepke M, Werner E, Biecker E, Schiedermaier P, Heller J, Neef M, et al. Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology. 2001;121:389\u201395.","journal-title":"Gastroenterology"},{"key":"449_CR26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/gut.2005.064329","volume":"55","author":"JH Henriksen","year":"2006","unstructured":"Henriksen JH, Fuglsang S, Bendtsen F, Moller S. Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics. Gut. 2006;55:380\u20137.","journal-title":"Gut."},{"key":"449_CR27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jhep.2010.03.013","volume":"53","author":"P Tandon","year":"2010","unstructured":"Tandon P, Abraldes JG, Berzigotti A, Garcia-Pagan JC, Bosch J. Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis. J Hepatol. 2010;53:273\u201382.","journal-title":"J Hepatol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0449-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-011-0449-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-011-0449-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:37:55Z","timestamp":1559097475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-011-0449-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,18]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1007\/s00535-011-0449-z","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,18]]}}}